Notice of the Second Extraordinary Shareholders' Meeting of 2026
Wuhan Huisheng Biotechnology Co., Ltd. (hereinafter referred to as "the Company") will hold the fifth meeting of the fourth board of directors on March 31, 2026, to review and approve the proposal to convene the second extraordinary shareholders' meeting of 2026, scheduled for April 17, 2026, at 14:00. The relevant matters of this shareholders' meeting are notified as follows:
I. Basic Information of the Meeting
- Shareholders' Meeting Session: Second Extraordinary Shareholders' Meeting of 2026
- Convener of the Meeting: Board of Directors
- The convening and holding of this meeting comply with the relevant provisions of the Company Law of the People's Republic of China, the Shenzhen Stock Exchange GEM Listing Rules, the Shenzhen Stock Exchange Self-Regulatory Guidelines No. 2 for Listed Companies on the GEM, and the Articles of Association of the Company.
- Meeting Time:
- (1) On-site meeting time: April 17, 2026, at 14:00;
- (2) Online voting time: The specific time for online voting through the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") system is from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on April 17, 2026; voting through the SZSE internet voting system can be done at any time from 9:15 to 15:00 on April 17, 2026.
- Meeting Method: Combination of on-site voting and online voting. The same voting right can only choose either on-site voting or one of the online voting methods. The Company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
- Record Date for Shareholding: April 14, 2026
- Attendees:
- (1) Ordinary shareholders or their agents holding shares of the Company on the record date, April 14, 2026, at the close of trading, registered with China Securities Depository and Clearing Corporation Limited Shenzhen Branch, have the right to attend the shareholders' meeting and may authorize agents to attend and vote. The agent does not need to be a shareholder of the Company (the format of the authorization letter is attached as Appendix II).
- (2) Company directors and senior management;
- (3) Witness lawyers hired by the Company and other personnel required to attend the shareholders' meeting.
- Meeting Location: Conference Room, 3rd Floor, No. 1 Zhonghua Road, Wuchang District, Wuhan, Hubei Province.
II. Matters for Discussion at the Meeting
- Proposal Coding Table for this Shareholders' Meeting
| Proposal Code | Proposal Name | Proposal Type | Remarks |
|---|---|---|---|
| 100 | General Proposal: All proposals except cumulative voting proposals | Non-cumulative voting proposal | √ |
| 1.00 | Proposal to extend the validity period of the shareholders' resolution for the issuance of A-shares to specific targets in 2024 | Non-cumulative voting proposal | √ |
| 2.00 | Proposal to authorize the board of directors and its authorized persons to handle matters related to the issuance of A-shares to specific targets | Non-cumulative voting proposal | √ |